The human pi-class glutathione S-transferase (hGST P1-1) is a target for structure-based inhibitor design with the aim of developing drugs that could be used as adjuvants in chemotherapeutic treatment. Here we present seven crystal structures of the enzyme in complex with substrate (glutathione) and two inhibitors (S-hexyl glutathione and g-glutamyl-(S-benzyl)cysteinyl-D-phenylglycine). The binding of the modi®ed glutathione inhibitor, g-glutamyl-(S-benzyl)cysteinyl-D-phenylglycine, has been characterized with the phenyl group stacking against the benzyl moiety of the inhibitor and making interactions with the active-site residues Phe8 and Trp38. The structure provides an explanation as to why this compound inhibits the pi-class GST much better than the other GST classes. The structure of the enzyme in complex with glutathione has been determined to high resolution (1.9 to 2.2 A Ê ) in three different crystal forms and at two different temperatures (100 and 288 K). In one crystal form, the direct hydrogen-bonding interaction between the hydroxyl group of Tyr7, a residue involved in catalysis, and the thiol group of the substrate, glutathione, is broken and replaced by a water molecule that mediates the interaction. The hydrogen-bonding partner of the hydroxyl group of Tyr108, another residue implicated in the catalysis, is space-group dependent. A high-resolution (2.0 A Ê ) structure of the enzyme in complex with S-hexyl glutathione in a new crystal form is presented. The enzyme-inhibitor complexes show that the binding of ligand into the electrophilic binding site does not lead to any conformational changes of the protein.
Introduction
The glutathione S-transferases (GSTs, E.C. 2.5.1.18) are a family of enzymes that protect cells against many xenobiotic substances and products of oxidative stress. They achieve this by conjugating electrophilic substrates to the tripeptide glutathione (GSH, g-Glu-Cys-Gly) which often makes them less toxic and more readily excretable from the body. Mammalian cytosolic GSTs exist either as homo-or heterodimers with a subunit molecular mass of about 25 kDa and with one active site per monomer (for a review, see Wilce & Parker, 1994) . They have been classi®ed into at least ®ve distinct families: alpha, mu, pi, sigma and theta based on studies of substrate speci®city and primary structures (Mannervik et al., 1985; Meyer et al., 1991; Meyer & Thomas, 1995) . The amino acid sequence identities between any two members within a class is typically greater than 70% whereas the ®gure is usually less than 30% between classes. The crystal structures of at least one representative from three of the mammalian class families have been determined: alpha (Sinning et al., 1993) , mu (Ji et al., 1992; Raghunathan et al., 1994) and pi (Reinemer et al., 1991 (Reinemer et al., , 1992 Dirr et al., 1994a; Garcõ Âa-Sa Âez et al., 1994) . These studies show that the different isozymes adopt the same protein fold and share some similar active-site features.
The human pi-class GST (hGST P1-1) has been implicated in the development of resistance of tumors towards various anti-cancer drugs (for reviews, see Coles & Ketterer, 1990; Waxman, 1990; Tsuchida & Sato, 1992; Hayes & Pulford, 1995) . A number of human tumors, including cancers of the colon, stomach, pancreas, uterine cervix, breast and lung have been shown to express raised levels of the hGST P1-1 enzyme (Coles & Ketterer, 1990; Tsuchida & Sato, 1992 , and references therein). Tumor cell lines tend to overexpress the hGST P1-1 isozyme in particular (Montali et al., 1995) . Moreover, it has been shown that selective inhibitors of hGST P1-1 potentiate the chemotherapeutic ef®cacy of anti-cancer drugs in resistant tumor cells (Morgan et al., 1996) . Both results stress the signi®cant potential that the design of highly potent hGST P1-1 selective inhibitors may have in increasing the therapeutic index of commonly used anti-cancer agents.
The ®rst crystal structure of a pi-class GST, from pig lung, was determined at 2.3 A Ê resolution in 1991 (Reinemer et al., 1991) . The structure revealed what has now turned out to be the canonical fold for all the cytosolic classes of GSTs (Dirr et al., 1994b; Wilce & Parker, 1994) . The enzyme is a homodimer with each subunit composed of two domains, as shown in Figure 1 ; the N-terminal (residues 1 to 74) and the C-terminal domains (residues 81 to 207). The glutathione binding site (Gsite) is made up of residues mostly from the Nterminal domain whilst the binding site for electrophilic substrates (H-site) is made up of residues predominantly from the C-terminal domain. A medium-resolution (2.8 A Ê ) structure of the human pi-class enzyme complexed with S-hexyl GSH (Reinemer et al., 1992) and high-resolution structures of the pig enzyme in complex with GSH sulfonate (Dirr et al., 1994a) and of a mouse pi-class enzyme in complex with GSH sulfonate, S-hexyl GSH and S-(p-nitrobenzyl) GSH (Garcõ Âa-Sa Âez et al., 1994) have since been published.
Here we present high-resolution structures of the human enzyme in complex with GSH, S-hexyl GSH and g-glutamyl-(S-benzyl)cysteinyl-D-phenylglycine (TER-117). The last compound has been reported as a potent inhibitor of hGST P1-1 (Lyttle et al., 1994) . As the medium-resolution structure of the human enzyme and the high-resolution structures of the pig and mouse enzymes have been analysed in detail elsewhere (Reinemer et al., 1992; Garcõ Âa-Sa Âez et al., 1994; Dirr et al., 1994a,b) we have chosen to give only a brief overview of the high-resolution model of the enzyme and to concentrate our analysis on features of the new structures that have not been discussed previously. The Figure 1 . The hGST P1-1 structure as determined from the new small cell C2 crystal form. Ribbon representation of the chain fold of the hGST P1-1 dimer complexed with S-hexyl GSH as viewed down the molecular diad. The location of the G and H-sites is denoted. Also indicated are the locations of the sulfate binding site and Mes binding sites. This Figure was produced using the computer program RIBBONS (Carson, 1991) .
Structure of Human GST P1-1 Complexes data presented here provide a wealth of detail about the enzyme's active site including information about protein¯exibility, water structure and ligand-protein interactions, all of which will be of great value in designing new inhibitors that may prove useful in chemotherapy.
Results and Discussion

S-hexyl GSH complex
The structure of this complex was previously reported at a resolution of 2.8 A Ê in the space group P4 3 2 1 2 (Reinemer et al., 1992) . By changing the reducing agent from b-mercaptoethanol to DTT and the buffer from phosphate to Mes, a new crystal form has been obtained that diffracts to a much higher resolution (see Materials and Methods; Table 1 ). The structure of the complex determined from the new crystal form has been re®ned to a resolution of 2.0 A Ê with a crystallographic R-factor of 19.7% (Table 2) . The model includes residues 2 to 209, the inhibitor molecule in both monomers and 364 solvent molecules. The high-resolution view of the complex largely con®rms the interpretation of the lower-resolution model (Figures 2(a) &  3(a) ).
There are a number of general structural features about the high-resolution model worth noting. There are two outliers in the Ramachandran plot and in both cases the electron density is excellent, the ®t unambiguous, and they are also outliers in Figure 2(a ± d) (legend on page 88)
Structure of Human GST P1-1 Complexes the mouse and pig enzymes (Dirr et al., 1994a; Garcõ Âa-Sa Âez et al., 1994) . One of them is Gln64, an active-site residue (f 82.2 , c 112.3 ), which was reported as an outlier in the lower resolution structure (Reinemer et al., 1992) . The high-energy conformation of Gln64 is thought to be an important feature of binding to GSH (Dirr et al., 1994b) . The other outlier, Thr141, is located in a loop after helix a5. The equivalent position is an alanine residue in the mouse and pig enzymes. The carbonyl group of Thr141 forms a hydrogen-bonding interaction with Arg182, a residue conserved in all the pi-class enzymes. The arginine residue has been mutated and this led to a lowering of activity (Manoharan et al., 1992a) , suggesting the structure in this region is critical for activity. There are two residues that adopt a cis con®guration. One of them is Pro53, a feature common to all GST structures, and thought to be essential for providing appropriate contacts to the GSH substrate (Reinemer et al., 1992; Dirr et al., 1994b) . There is a second residue, Pro2, which also adopts a cis con®guration but the preceding residue is only observed in the P4 3 2 1 2 crystal forms where it is stabilized by crystal contacts. The temperature factor trend for the C2 complex is shown in Figure 4 . The mean temperature factor is approximately 22 A Ê 2 (Table 2 ) and there are ®ve regions of signi®-cantly higher than average temperature factors. Two of them are at the N and C termini, re¯ecting the mobility of the protein tails. The region about helix 2 is very mobile and is associated with poor side-chain electron density for some of the surface residues. The apices of the helical towers of the Cterminal domain (helices 4 and 5) do not contact other protein elements and hence tend to be morē exible. There are four buried charge groups and all are involved in compensating interactions: Arg70 forms a salt link with Asp94, Asp90 forms a salt link with Arg74, Asp157 forms a salt link with Arg100 and Asp152 takes part in multiple hydrogen-bonding interactions with two main-chain amide hydrogen atoms and the hydroxyl group of Tyr179. There are only two cavities of note in the dimeric molecule. They are located between the N and C-terminal Figure 2 . Stereo diagrams of the ®nal 2F obs À F calc omit electron density maps of the complexes in the vicinity of the substrate binding sites of hGST P1-1. The substrate or inhibitor was taken out of the model and a round of positional re®nement performed to reduce model bias. The maps were calculated using all re¯ections (see Table 1 ) and contoured at the 1.0s level. hGST P1-1 complexed with (a) S-hexyl GSH (C2 form, 100 K), (b) GSH (C2 form, 288 K), (c) GSH (C2 form, 100 K), (d) GSH (P2 1 2 1 2 1 form, 100 K), (e) GSH (big cell C2 form, 100 K) and (f) TER-117 (C2 form, 288 K).
domains of each monomer, related to each other by the 2-fold axis of the dimer. The cavity in each monomer is surrounded by the sidechains of Arg13, Ala16, Ser65, Asn66, Cys69, Glu97, Arg100 and Asp157. The volume of the cavity is approximately 90 A Ê 3 and is ®lled with a network of water molecules.
Mes buffer is an essential ingredient for growth of the C2 crystal form and this can be explained by the location of the buffer molecule in a surface pocket formed from two crystallographically related molecules where it is involved in multiple van der Waals contacts between the GST molecules ( Figure 1 ). The ring of the Mes molecules stacks Figure 3 (a) (legend on page 90) Structure of Human GST P1-1 Complexes perpendicular to the aromatic ring of Trp28, the nitrogen atom makes contact with Glu197 and the sulfonic acid moiety does not make any contacts but sticks out freely towards solvent. A third binding site for Mes has been identi®ed at the bottom of the dimer interface, where it bonds between two symmetry-related tyrosine residues at position 79. The electron density is weaker for this Mes site in comparison to the others suggesting the site is either partially occupied, the buffer molecule is highly mobile or both. In addition to the Mes molecules, another ingredient of the crystallization mixture has been observed in the high-resolution structures. A sulfate ion is located in the middle of the dimer interface bound between the guanidinyl groups of Arg70 from each monomer and is involved in multiple water-mediated protein contacts (Figure 1 ).
There are a number of differences between the high-resolution structure and the medium-resolution published structure (Reinemer et al., 1992) . The alpha-carbon atoms of the two structures superimpose with a r.m.s. deviation of 0.60 A Ê . This high value re¯ects the inaccuracy of the mediumresolution structure (non-crystallographic symmetry (n.c.s.) restraints were not employed in the re®nement of the published structure), uncertainty in the placement of some residues in surface loops and some space-group-dependent effects. The major outliers (> 1 A Ê r.m.s. deviation) on superposition due to placement uncertainties in the published structure are residues 36, 39 to 42, 45 to 46, 58 to 59, 83, 145, 168 and 187 in monomer A and residues 27, 137 and 209 in monomer B. Many of these residues are either glycine residues or adjacent to glycine residues and the lack of side-chain density made interpretation of the medium-resolution electron density map uncertain. The major outliers due to the presence or absence of crystal contacts are residues 2, 27, 108, 109, 112 to 114 and 205 of monomer A and residues 2, 27, 59, 112, 113, 116, 166 to 168, 171 to 175, and 205 of monomer B. Many of the surface side-chains exhibit different positions and orientations when the structures are superimposed. The placement of these side-chains is more certain in the electron density maps of the C2 crystal form because of the much higher resolution of the data and better ordering of the crystal due to cryocooling. The two monomers of the high-resolution structure superimpose with a r.m.s. deviation on alpha-carbon atoms of 0.02 A Ê . This low value is due, in large part, to the n.c.s. restraints used throughout at the re®nement (see Materials and Methods). This value can be compared to the higher value of 0.49 A Ê from superposition of the monomers of the published structure where no n.c.s. restraints were employed during re®nement (Reinemer et al., 1992) . Other problems of the published structure include incorrect puckering of proline residues, incorrect side-chain rotamers and a poorer Ramachandran plot, all conditions symptomatic of the limited resolution. Glu197 of the monomer A is no longer a Ramachandran outlier in the new structure. The high-resolution structure indicates numerous water-mediated interactions between the GSH molecule and protein, particularly involving the g-carboxylate group (Figure 3 ). Arg13 and Gln51 were reported to form hydrogen bonds with the g-carboxylate group and Lys44 and Gln51 with the carboxylate group of the glycyl moiety (Reinemer et al., 1992) but this is no longer the case, ruled out due to inappropriate hydrogen-bonding geometry. However, weak or transient hydrogen-bonding interactions between these residues and GSH are likely since they are within 3.4 A Ê of the substrate. The hexyl moieties of the inhibitor from the two monomers of the C2 crystal form superpose well in contrast to the published results of the lower-resolution structure (Reinemer et al., 1992) . The major differences in the secondary structure designations between this and the previously published ones (Reinemer et al., 1992) are as follows: strand b2 starts at residue 28 (previously 29), helix a2 is bent at Gly41, helix a3 is extended by three residues at the C terminus (residues 74 to 76), there is no 3 10 helix between residues 170 and 172, helix a8 extends to residue 194 (previously 193) and is kinked at Ser195 before continuing onto residue 199 as a helix.
The most signi®cant difference between the P4 3 2 1 2 and C2 forms (and including the GSH com- (b) is as follows: blue, S-hexyl GSH (C2 form, 100 K); black, S-hexyl GSH (P4 3 2 1 2 form, 288 K); red, GSH (C2 form, 288 K); green, GSH (C2 form, 100 K); cyan, GSH (P2 1 2 1 2 1 form, 100 K); magenta, GSH (big cell C2 form, 100 K); and yellow, TER-117 (C2 form, 288 K). (c) For human (GSH, C2, 100 K, denoted by the black trace), mouse (GSH sulfonate, denoted by the red trace; Garcõ Âa-Sa Âez et al., 1994) and pig (GSH sulfonate, denoted by the green trace; Dirr et al., 1994a) enyzmes. The continuous lines are for monomer A and the broken lines for monomer B.
Structure of Human GST P1-1 Complexes plexes discussed below) concerns a hydrogenbonding interaction between the hydroxyl group of Tyr108 and the carbonyl group of Asn204 observed in the former. In the C2 form, a peptide¯ip is observed, resulting in the hydroxyl group of Tyr108 bonding instead to the amide nitrogen of Gly205. This interaction has also been observed in the mouse and pig pi-class structures (Garcõ Âa-Sa Âez et al., 1994; Dirr et al., 1994a) . The reason for the difference appears to be crystal contacts. In the P4 3 2 1 2 form there are extensive crystal contacts in this region of both monomers involving mainchain atoms of residues Gly204, Asn206 and Gly207. There are no such interactions in either monomer of the C2 form. Hence the interaction observed in the P4 3 2 1 2 form is likely an artifact of the crystallization.
GSH complex
To date, none of the pi-class GSTs has been crystallized in the presence of the physiological substrate, glutathione. We have solved the structure of the complex in three different crystal forms and at two different temperatures (Table 1 ). All the structures are well determined at high resolution (1.9 A Ê to 2.2 A Ê ) as judged by good re®nement statistics and stereochemistry (Table 2) as well as by highquality electron density maps (Figure 2 ).
With one exception (see below), there are no observable differences between the structures determined from data collected at 288 K and 100 K (GSH complexes no. 1 and no. 2 in Table 1 (Table 2) . This is particularly evident in the drop of about 20 A Ê 2 in the region of the helical towers of the C-terminal domain. The major difference between the two structures concerns the V-shaped dimer interface where the angle of the V in the room temperature structure has increased by 2.0 compared to the 100 K structure where the angle is 22.5
. This results in signi®cant movements of the helical towers of the C-terminal domain upon superposition of the two structures (with r.m.s. deviations of nearly 0.4 A Ê in the alphacarbon positions) but does not result in any changes in monomer-monomer contacts which are concentrated in the base of the V-shaped interface. These data are an important control since most of our crystallographic work on hGST P1-1 crystals is now performed on cryocooled crystals and we were concerned that the low temperature of data collection might lead to artifacts in interpreting changes in the models. These and the other models described here show that cryocooling causes a shrinkage in the unit cell leading to narrowing of the V-shaped dimer interface transmitted through crystal contacts. The data re¯ect the inherent¯exi-bility of the enzyme which has been shown to be an essential feature of the catalytic mechanism .
The structures of the complex grown in different space groups are very similar after taking account of crystal packing differences. The P2 1 2 1 2 form (GSH no. 3 in Tables 1 and 2 ) superimposes closely to the small cell C2 form (GSH no. 2). The r.m.s. deviation on superposition of alpha-carbon atoms is 0.18 A Ê and the two regions of maximum deviation are located in helix 2 (maximum deviation of 0.54 A Ê at Val35) and a hairpin loop at Asp59 (deviation of 0.63 A Ê ). Both these regions exhibit high Bfactors and poor electron density in both crystal forms. The overall close similarity is also borne out in the temperature factor plot of the two (Figure 4 ). In the big cell C2 crystal form (GSH no. 4 in Tables 1 and 2) there is an additional monomer in the asymmetric unit with the physiological dimer generated by crystallographic symmetry. This crystal form has allowed us to compare three monomers from the one crystal which are involved in different crystalline environments. Each monomer superimposes on the other with r.m.s. deviations on alpha-carbon atoms as follows: 0.42 A Ê for monomers A versus B (maximum deviations of up to 1.9 A Ê in helix 2, 2.0 A Ê for Gln137 and 1.2 A Ê for Gly207), 0.12 for monomers A versus C (maximum deviations of 0.5 A Ê in helix 2) and 0.38 for monomers B and C (maximum deviations of up to 1.5 A Ê in helix 2, 2.1 A Ê for Gln137 and 1.3 A Ê for Gly207). The deviations at Gln137, Gly207 and in the region of helix 2 are all due to crystal contacts. Each monomer superposes very closely (less than 0.4 A Ê r.m.s. deviation of alpha-carbon atoms on superposition) with the monomers of the small cell C2 crystal form (GSH no. 2). The major deviations between the two forms can be ascribed to either crystal contacts or uncertainty in the placement of some atoms, particularly in helix 2 which possesses fairly high temperature factors in the small cell C2 form (Figure 4) . The largest deviations of 1.3 A Ê occur at residue 36 of helix 2 and 1.9 A Ê at Gln137, which is involved in a crystal contact in the big cell C2 form. In addition to the Ramachandran outliers reported for the other complexes, Asn110 of monomer A is also an outlier due to crystal contacts. The temperature factor values for the big cell C2 form are dramatically lower than the other crystal forms with a mean temperature factor of only 12.0 A Ê 2 ( Figure 4, Table 2 ), close to the value of 14.1 A Ê 2 derived from a Wilson plot of the diffraction data. Nevertheless, a similar trend of temperature factors to the other complexes can be discerned with peaks corresponding to the apical towers of the Cterminal domain and in the surface helices between residue 160 and 200. In this crystal form, there is no evidence of helix 2 mobility and this is due to crystal contacts in this region in all three monomers. The traces for the B monomer (Figure 4(b) ) and C monomer (not shown) are very similar to that of the A monomer.
Although the temperature factor trend of the small cell C2 structure (GSH no. 1) is very similar to the S-hexyl GSH complex in the same space group (Figure 4) , the mean temperature factor of 76 A Ê 2 for the substrate is much higher than the substrates and inhibitors of the other complexes (Table 2 ). This high value re¯ects the low occupancy of the substrate: if the temperature factors of the substrate are reset to the value of the contacting side-chains (approximately 30 A Ê 2 ), the occupancy re®nes to a value of 0.59 for monomer A and 0.54 for monomer B. GSH was not added to any of the crystallization trails but was present because it is used as eluant in the protein puri®-cation procedure (Parker et al., 1990) . Attempts were made to remove bound GSH from the enzyme by exhaustive dialysis. Protein crystallized from this treatment resulted in the small cell C2 form labeled GSH no. 1 in Tables 1 & 2 . This treatment has lead to only partial loss of substrate as evidenced by the lower occupancy of GSH relative to the other complexes reported here.
With one signi®cant exception, the substrate binds in identical fashion in all the crystal forms and the contacts between GSH and protein are identical with those observed for the GSH moiety in the S-hexyl GSH complexes (Figure 2 ). The exception is the direction of the sulfur atom of GSH which points away from Tyr7 in the big cell C2 form (Figure 2 (e) and see Figure 6 ). The direct hydrogen-bonding interaction between GSH and the tyrosine residue observed in the other crystal forms is replaced by a water-mediated interaction between the two. The same interaction is observed in all three monomers of the asymmetric unit. This is a surprising result because only direct interactions between the two have been observed previously in other crystal structures of GSTs (Reinemer et al., 1991; Ji et al., 1992; Reinemer et al., 1992; Sinning et al., 1993; Dirr et al., 1994a; Garcõ Âa-Sa Âez et al., 1994; Raghunathan et al., 1994; Lim et al., 1994; McTigue et al., 1995; Ji et al., 1995) . The reason for the difference is not clear but may be related to the fact that the big cell C2 crystal form grows at low temperatures and low pH (5.4 to 6.0) only, in contrast to the other crystal forms which were grown at room temperature and at higher pH (5.8 to 6.4).
The H-site residues of the GSH complex structures superimpose well with the exception of two residues, Val10 and Val35. There is evidence of two rotamers of Val10 in all three monomers of the big cell C2 form. The side-chain of Val35, located on helix 2, is associated with high temperature factors and quite often poor density in the various complexes due to the high mobility of the entire helix. The complexes grown in the small cell C2 crystal form (GSH no. 1 and no. 2) superimpose closely with the S-hexyl GSH complex grown in the same space group. The r.m.s. deviations in alpha-carbon positions on superposition are less than 0.2 A Ê with maximum deviations less than 0.4 A Ê . A chain of water molecules, between helix 4 and the C-terminal loop, runs along the border of the H-site and is not disturbed by the binding of the hexyl moiety ( Figure 5 ). There are hydrogenbonding interactions between these water molecules and the side-chains of Arg13, Arg100, Asp157, Tyr108 and Asn204 as well as with the GSH molecule. It is highly likely that some of these water molecules interact with polar substrates when bound in the H-site.
TER-117 complex
TER-117 (g-glutamyl-(S-benzyl)cysteinyl-D-phenylglycine) is the most selective hGST P1-1 inhibitor reported to date. The compound has a K i of 0.4 mM with a competitive pro®le versus GSH in enzymatic activity measurements, while the K i for isozymes of the alpha and mu classes is over 10 mM (Koehler et al., 1997) . There are no signi®-cant conformational changes that occur on binding TER-117; the alpha-carbon superposition of this complex and the GSH complex (the C2 form measured at 288 K) leads to a r.m.s. value of 0.13 A Ê with the largest deviation less than 0.4 A Ê . The GSH moiety of this inhibitor binds in identical fashion Figure 5 . Stereo diagram of the 2F obs À F calc electron density map in the vicinity of the water-®lled tunnel spanning the G and H-sites as observed in the GSH (C2 form, 100 K) complex. The map was calculated using all re¯ections (see Table 1 ) and contoured at the 0.7s level.
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with that observed in the GSH and S-hexyl GSH complexes described above (Figures 2(f) and 3(b) ). The sulfur atom of GSH is located in the same position as found in the GSH complexes (of the small C2 crystal form). The phenyl substituent, coming off the glycyl moiety of GSH, is nestled in a hydrophobic crevice made up of Phe8, Val35, Trp38 and the benzyl group of the inhibitor. The phenyl ring stacks perpendicular to the ring of Phe8 and forms van der Waals interactions with Trp38 (Figures 2(f)  and 3(b) ). The benzyl ring is located in the H-site and is stacked between the aromatic rings of Phe8 and Tyr108. It also stacks at an oblique angle to the phenyl ring of the modi®ed GSH (Figures 2(f)  and 3(b) ). The benzyl moiety superposes well on the hexyl moiety of the S-hexyl GSH complexes ( Figure 6 ). Alternative or even multiple H-sites have previously been proposed (Reinemer et al., 1992) so this and the S-hexyl GSH complexes demonstrate that both alkyl and aromatic substrates can bind in the same H-site. The temperature factor trend most closely resembles the trend for the GSH complex in the same space group, measured at the same temperature (Figure 4 ). This indicates that an occupied H-site has little in¯uence on the mobility of the molecule as a whole.
The binding of TER-117 shows many similarities to the recently published structure of another inhibitor, ethacrynic acid (EA) and its GSH conjugate, bound to hGST P1-1 (Oakley et al., 1997; Figure 6 ). The GSH moieties adopt identical conformations and the aromatic rings of EA and EA-GSH stack against the side-chain of Tyr108 in similar fashion to the benzyl ring of TER-117. EA-GSH does form some additional interactions in the H-site: the chlorine atoms interact with Ile104 and the butyryl group interacts with Val10. However, EA-GSH does not have the equivalent of the phenyl ring in TER-117 so as to interact with additional G-site residues.
The structure of the TER-117 complex explains why it is a much better inhibitor of the pi-class enzyme than the alpha and mu-class enzymes. The phenyl moiety of the inhibitor contacts lipophilic regions whilst maintaining the multiple hydrogenbonding interactions between the rest of the GSH molecule and the G-site as seen in other GSHbased complexes. The substitution of the glycyl moiety in GSH by D-phenylglycine in TER-117 would result in steric clashes in the alpha and muclass enzymes (Figure 7 ). In the case of alpha class hGST A1-1, the bulky modi®cation would clash with Phe220 and Phe222 (Sinning et al., 1993) whilst in the case of mu class hGST M2-2, it would clash with Trp7, Met34 and Arg42 (Ji et al., 1992) . Although the crystal structure of the apo form of hGST A1-1 suggests the C-terminal helix, in which Phe220 and Phe222 reside, can be highly mobile (Cameron et al., 1995) , the structure-activity relationships derived by Koehler et al. (1997) show that large substituents off the glycly moiety result in poor alpha-class inhibitors. This suggests the H-site of the alpha-class enzyme has de®ned limits to its plasticity in accepting bulky substrates.
Comparisons to other pi-class GSTs
Our high-resolution models superimpose well with those of the pig (Dirr et al., 1994a) and mouse pi-class GST crystal structures (Garcõ Âa-Sa Âez et al., 1994) as expected from high pairwise sequence identities of over 80%. The superpositions of the GSH (100 K) complex with mouse (1GLP) and pig (2GSR) enzymes yields r.m.s. values on alpha-carbon atoms of 0.49 A Ê and 0.56 A Ê , respectively. The most signi®cant difference between the human and pig enzymes, noted previously (Reinemer et al., Figure 6 . Superposition of published pi-class GST crystal structures, including the structures presented here, within the vicinity of the active site. The Figure was generated with the program package INSIGHT II (Molecular Simulations Inc., San Diego, CA, USA.). The structures are colored as follows: pink, human pi with S-hexyl GSH (C2 form, 100 K); green, GSH (C2 form, 100 K); magenta, GSH (big cell C2 form, 100 K); mauve, TER-117 (C2 form, 288 K); orange, ethacrynic-GSH ; purple, ethacrynic acid ; red, mouse pi with GSH sulfonate (PDB identi®er: 1GLP); yellow, mouse pi with S-(pnitrobenzyl) GSH (PDB identi®er: 1GLQ); blue, mouse pi with Shexyl GSH (PDB identi®er: 2GLR); and cyan, pig pi with GSH sulfonate (PDB identi®er: 1GSR). 1992), occurs in the region of helix 2 where an irregular helical structure in the pig enzyme is replaced by a two-residue insertion (Glu40 and Gly41) leading to a bent helical structure with a kink at Gly41 in the human enzyme. The human and mouse enzymes superimpose well in this region with the latter also possessing a two-residue insertion in the same place. However, the second a-helix is replaced by a 3 10 helix in the mouse enzyme (Garcõ Âa-Sa Âez et al., 1994) . Surprisingly, Trp38, a residue that makes contacts with GSH, is retained in the same position in all three enzymes despite the two-residue insertion (Figure 6 ). The angle of the V-shaped dimer interfaces in the human (small cell C2 form measured at room temperature) and mouse enzymes are the same whereas the angle is approximately 0.5 smaller in the pig enzyme. The data sets for the pig and mouse enzyme complexes were both measured at room temperature. The smaller angle for the pig enzyme can be attributed to crystal contacts at the top of helix 4 (Dirr et al., 1994a) .
A comparison of the temperature factor trends for the human, mouse and pig enzymes is shown in Figure 4 (c). The overall trends are very similar but there are regions of signi®cant differences. The region of helix 2 is less mobile in the mouse and pig enzymes, but in both cases crystal contacts appear responsible. The pig enzyme has a high Bfactor in the hairpin turn at about residue 57. This turn is not involved in crystal contacts and its sequence is conserved between all species except the nematodes. The reason for the difference is not clear. The mouse enzyme has a higher B-factor in the N-terminal end of helix 6 and this correlates with crystal contacts lowering the mobility of this region in the other two enzymes. Finally, the loop between helices 6 and 7 is more mobile in the pig enzyme because of crystal contacts in the same region of the mouse and human enzymes. The consensus trend is as follows: in the N-terminal domain, helix 2 exhibits increased¯exibility with respect to the rest of the protein, there is a region of¯exibility about the linker peptide joining the domains (around residue 80) and the C-terminal domain has regions of high mobility, particularly in the apical helical towers and the surface helices towards the C terminus. All these regions contribute residues to the G and H-sites and hence protein mobility may be a signi®cant contributor to enzymatic activity, as suggested recently on the basis of kinetic studies Ricci et al., 1996) .
We have noted the presence of a water-®lled cavity in the domain interface of the human enzyme. The same sized cavity is retained in the mouse and pig enzymes, and remarkably, the similarity extends to an almost identical pattern of water structure (Garcõ Âa-Sa Âez et al., 1994; Dirr et al., 1994a) . The chain of water molecules running through the H-site of the human enzyme ( Figure 5 ) has also been observed in the pig and mouse enzymes (Dirr et al., 1994a; Garcõ Âa-Sa Âez et al., 1994) and in most cases the position of the individual solvent molecules superimpose well.
The glutathione backbones of the various complexes superimpose closely and the H-site ligands bind in very similar positions. Of particular note, is the very close superposition of the benzyl ring of the TER-117 complex and the benzyl ring of the S-(p-nitrobenzyl) GSH complex (Garcõ Âa-Sa Âez et al., 1994) of the mouse enzyme ( Figure 6 ). Even though mammalian pi-class GSTs share high levels of sequence identity, they can display large variations in speci®c activites towards various substrates (Mannervik & Danielson, 1988; Hayes & Pulford, 1995) . These variations can be attributed to rather small differences in the H-sites of each enzyme. There is some variation in the H-site due to replacement of Val35 by methionine or isoleucine and Ile104 by an alanine or valine in the pig and mouse enzymes, respectively. Because of the openness of the H-site, these changes do not lead to compensating movements of other residues. Iso- forms of the human enzyme have been discovered which display different heat stabilities, speci®c activities and af®nities for electrophilic substrates. The isoforms differ in a single amino acid residue, isoleucine or valine, at residue 104 (Zimniak et al., 1994) . These results emphasise the importance of the size, surface topology and polarity of the H-site for binding and catalysis.
Implications for mechanism of binding and catalysis
Site-directed mutagenesis studies (Kong et al., 1992; Kolm et al., 1992; Manoharan et al., 1992b) support a catalytic role for Tyr7 whereby a hydrogen bond between the Tyr7 hydroxyl group and GSH stabilizes the thiolate anion form of the substrate. This residue is located in a hydrophobic pocket surrounded by residues Phe8, Val10, Gly12, Cys14 and Pro53 and is only partially exposed to solvent. With the exception of the big cell C2 crystal form, the distance between the hydroxyl group of Tyr7 and the sulfur atom of GSH is consistently 3.4 (AE0.2) A Ê in all the complexes studied here. A similar positioning of the sulfur atom has been observed in all the complexes of the pig and mouse pi-class GSTs (Dirr et al., 1994a; Garcõ Âa-Sa Âez et al., 1994) . In the big cell C2 form, the sulfur atom points towards the H-site and a water molecule is positioned close to where the sulfur atom is located in the other crystal forms (Figures 2(e) &  6 ). There is no longer a direct hydrogen bond between Tyr7 and GSH but there is an indirect hydrogen bond between the two, mediated through the water molecule. A very similar arrangement is observed in the S-hexyl GSH complex (Figures 2(a) & 6) . (The water molecule is not present in the lower-resolution P4 3 2 1 2 model but there is a 2s peak corresponding to its position in the ®nal electron density map of this crystal form.) This is surprising because the sulfur atom of GSH in the TER-117 complex presented here and in the S-(p-nitrobenzyl) GSH and S-hexyl GSH complexes of the mouse enzyme is positioned within direct hydrogen-bonding distance of Tyr7 (Figure 6 ). The reason for this variability may be related to the nature of the H-site ligand. The hexyl chain is verȳ exible and could adopt a variety of conformations whereas more bulky substituents may determine the positioning of the sulfur atom to avoid steric clashes with protein side-chains in the H-site. These observations open up the possibility that the stabilization of the GSH thiolate may be watermediated under some circumstances. The pK a of Tyr7 is lower than expected with a value of about 7.9 (Meyer et al., 1993) suggesting that a portion of the residue could exist in the tyrosinate form and that it may function as a hydrogen-bond acceptor of the GSH substrate. With the exception of the big cell C2 crystal form, there is no evidence in our high-resolution structures of any water molecules in hydrogen-bonding distance of either the hydroxyl group of Tyr7 or the thiol sulfur atom of GSH. There is a clear hydrogen bonding interaction between the hydroxyl group of Tyr7 and the backbone amide group of Arg13 (distance of 2.9 A Ê ) and this interaction could stabilize the tyrosinate state. The question as to whether Tyr7 is protonated remains controversial. The recent ®nding that a serine or threonine residue replaces the role of the tyrosine residue in theta-class GSTs (Rossjohn et al., 1996) suggests the protonated form could be the physiologically relevant species. An alternative explanation for the observation of a water-mediated contact between Tyr7 and GSH in the big cell C2 form comes from NMR measurements of GSH bound to the enzyme (M. Nicotra, M. Paci, M. Sette, A. J. Oakley, M. W. Parker, M. Lo Bello, A. M. Caccuri, G. Federici & G. Ricci, unpublished results) . These results are compatible with the protonated form of GSH binding in the big cell C2 form where the low pH and low temperature conditions of the crystallization would favor such a complex.
Another tyrosine residue has recently been shown to be involved in certain catalytic reactions of pi-class GSTs. Tyr108, located in the H-site, has been shown to enhance Michael additions of GSH to electrophilic substrates Oakley et al., 1997) . This residue is strictly conserved in all the pi-class sequences and does not move in any of the complexes determined here, irrespective of whether the H-site is empty or not. In our original publication (Reinemer et al., 1992) , the hydroxyl group of this residue was reported to hydrogen bond to Asn204. The analysis here demonstrates this was an artifact of the crystallization and that its hydrogen-bonding partner in solution is likely Gly205. Mutagenesis experiments are underway to con®rm this ®nding.
There are four regions of high mobility common to most of the complexes: the N and C-terminal tails, helix 2 and the apical helical towers of the Cterminal domains. Helix 2 is readily proteolysed in solution and the potential importance of its exibility has been remarked upon previously (Lo Bello et al., 1993b) . Its inherent¯exibility helps explain the observed inactivation of the enzyme by thiol-reactive agents that bind to Cys47, a residue located directly underneath the helix. Although partially buried under helix 2, this cysteine residue would be reactive to attack through movements of helix 2 resulting in the helix moving into the G-site and blocking GSH binding (Wilce & Parker, 1994) . It has been postulated that helix 2 undergoes conformational changes on binding to GSH (Lo Bello et al., 1993a; Ricci et al., 1996) and this might be controlled by the redox reactivity of Cys47 (Nishihara et al., 1991; Tamai et al., 1991; Lo Bello et al., 1993b) . Furthermore, the molecular mechanism of cooperativity caused by mutation of Cys47 probably involves movements of helix 2 Ricci et al., 1995) . The mobile C-terminal regions contribute residues that line the H-site, and exibility in the H-site has been implicated in certain reactions of the enzyme Lo Bello et al., 1997) .
Materials and Methods
Crystallization, data collection and processing
The protein was overexpressed in Escherichia coli and puri®ed as described . Because the protein was puri®ed by af®nity chromatography using GSH as an eluant, the ®nal protein sample had GSH bound to the G-site. Crystallization was performed by the hanging-drop vapor diffusion method (McPherson, 1982) using 24-well tissue-culture plates. A 2 ml droplet of a 8 mg/ml protein solution containing 10 mM phosphate buffer (pH 7.0), 1 mM EDTA and 2 mM mercaptoethanol, was mixed with equal volumes of reservoir solution. S-hexyl GSH was synthesised using an established method (Parker et al., 1990) and g-( L)-glutamyl-( L)-(S-benzyl)cysteinyl-D-phenylglycine (TER-117) was synthesised according to Lyttle et al. (1994) . The drop was applied to a siliconised coverslip which was sealed to the top of the well with vacuum grease. Each well contained 1 ml of reservoir solution. The trials were carried out at a constant temperature of 22 C unless otherwise stated. All crystals took between one and four days to appear and grew to ®nal size in about a week.
The C2 (GSH no. 1 and no. 2) and P2 1 2 1 2 1 (GSH no. 3) forms of the GSH complex were crystallized with a reservoir solution consisting of 20 to 34% (w/v) ammonium sulfate, 50 to 80 mM DTT and 100 mM Mes buffer (pH range 5.8 to 6.4). Both crystal forms grow as thick plates. The large cell C2 (GSH no. 4) crystals were grown under the same conditions at 4 C and lower pH (5.4 to 6.0). The P2 1 2 1 2 1 crystals are very rare but can be found in the same drops as the C2 crystals. The C2 form of the S-hexyl GSH complex was crystallized under the same conditions but with the addition of 10 mM S-hexyl GSH to the reservoir solution. For the P4 3 2 1 2 form of the S-hexyl GSH complex, the reservoir conditions consisted of 12 to 17% ammonium sulfate, 30 to 40 mM DTT, 600 to 700 mM phosphate buffer (pH range 5.8 to 6.2) and 10 mM S-hexyl GSH. The TER-117 complex is formed by streaking a crystallization drop containing the C2 crystals of the GSH complex with a solid compound of TER-117 two days prior to data collection.
The X-ray diffraction data were collected using a MARResearch area detector with CuK a X-rays generated by a Rigaku RU-200 rotating anode X-ray generator. In all cases only one crystal was required for each data set. Low-temperature data sets were collected using an Oxford Cryosystems Cryostream Cooler. Prior to¯ash-freezing, the crystals were transferred to arti®cial mother liquor containing between 15 and 20% (v/v) glycerol. All the diffraction data were processed and analysed using programs in the HKL (Otwinowski, 1993) and CCP4 (1994) suites. The relevant data statistics are presented in Table 1 .
Structure solution and refinement
The structures of the enzyme in the new crystal forms were determined by molecular replacement using the program package AMoRe (Navaza, 1994) . The search model consisted of the S-hexyl GSH complex dimer model (Reinemer et al., 1992) which had the S-hexyl GSH inhibitor and water molecules removed. In all cases, re¯ections within the resolution range of 15 to 4 A Ê were used. The relevant molecular replacement statistics are given in Table 3 . For the small cell C2 (S-hexyl GSH complex) and P2 1 2 1 2 1 (GSH no. 3) crystal forms, both of which have a single dimer in the asymmetric unit, the solutions corresponded to the highest peaks in both rotation and translation functions. The next highest peaks (4.6s in the S-hexyl GSH complex and 4.0s in the GSH complex in the rotation functions) were less than half the height of the correct peaks. In the large cell C2 (GSH no. 4) crystal form there are three monomers in the asymmetric unit. The ®rst solution was obtained from the second highest rotation and highest translation function peaks. This solution revealed the location of the ®rst two monomers which were found to associate and form a dimer in the asymmetric unit. The highest rotation function peak yielded a single strong peak in the translation function which placed the dimeric search model on a crystallographic 2-fold axis. Hence the third monomer forms a dimer through a crystallographic relationship. The next highest peaks in the rotation (5.1s) and translation functions were less than half the height of the correct ones.
All structures were re®ned using similar protocols. Progress was monitored throughout by consistent decreases of the free R-value (Bru È nger, 1992). Rigid body re®nement in X-PLOR version 3.1 (Bru È nger, 1993) was used to improve the molecular replacement solutions of the new crystal forms and to compensate for any possible changes in crystal packing in the previously determined crystal forms. As the asymmetric unit of each crystal form contained at least two GST monomers, use was made of non-crystallographic symmetry (n.c.s.) restraints on all non-hydrogen atoms throughout the course of re®nement. Attempts to remove the n.c.s. restraints in the ®nal rounds of re®nement always lead to increases in the free R-values and hence weak restraints were retained. However, n.c.s. restraints were removed for all residues involved in crystal contacts. The models were subjected to simulated annealing at 3000 K with X-PLOR (Bru È nger, 1993) . The Engh & Huber parameter set was used (Engh & Huber, 1991) . Where necessary 2F inhibitor À F native electron density maps were further improved by ten cycles of 2-fold non-crystallographic averaging using MAMA (Kleywegt & Jones, 1994a) , RAVE (Kleywegt & Jones, 1994a ) and CCP4 (1994) program suites. The electron density maps calculated from these models allowed unambiguous placement of the substrate/inhibitor in each case and revealed the location of numerous solvent molecules. The bond lengths and angles of the substrate/inhibitor molecules were derived from structures built and energy minimised using programs in the BIOSYM software suite (Molecular Simulations Inc., San Diego, CA, USA.). Solvent atoms were only accepted if they appeared as peaks with a signal of more than 4 times the r.m.s. error in F o À F c difference maps, reappeared in subsequent 2F o À F c maps, took part in at least one hydrogenbonding interaction and had temperature factors less than 80 A Ê 2 . The models were cycled through a few rounds of rebuilding with O (Jones et al., 1991) and positional and highly restrained individual B-factor re®ne-ment with X-PLOR (Bru È nger, 1993) . Finally, bulk solvent corrections were applied using all data. Details of the ®nal re®nement runs are given in Table 2 . The ®t of the substrates/inhibitors to the ®nal electron density maps is shown in Figure 2 indicating the high quality of the maps. A stereochemical analysis of the re®ned structures with the program PROCHECK (Laskowski et al., 1993) gave values either similar to or better than expected for structures re®ned at similar resolutions.
Analysis of structures
Modeling was performed on either a Silicon Graphics Indigo2 Extreme or Maximum Impact computer graphics system using the graphics software packages O (Jones et al., 1991) , INSIGHT (Molecular Simulations Inc., San Diego, CA, USA.) and RIBBONS (Carson, 1991) . The nature and position of secondary structure elements were calculated using the secondary structure de®nition encoded in the program PROMOTIF (Hutchinson & Thornton, 1996) . Atomic models were superimposed with LSQMAN (Kleywegt, 1996) . Atomic interactions were computed using the program CONTACT (CCP4, 1994) . Solvent accessibility calculations were performed with the program DSSP (Kabsch & Sander, 1983) . Cavity calculations were performed with VOIDOO (Kleywegt & Jones, 1994b) . Final coordinates and structure factors have been deposited in the Brookhaven Protein Data Bank (accession codes 5GSS, 6GSS, 7GSS, 8GSS, 9GSS and 10GS). Coordinates will be on hold for one year.
